Literature DB >> 3681717

The effects of in vitro application of purified botulinum neurotoxin at mouse motor nerve terminals.

J O Dolly1, S Lande, D W Wray.   

Abstract

1. Purified botulinum neurotoxin type A (10 nM) was applied in vitro to mouse diaphragm muscles. Intracellular micro-electrode recordings were made continuously in single fibres. 2. This treatment reduced end-plate potential (e.p.p.) amplitudes with a time to half-maximal effect of about 75 min at 22-25 degrees C. E.p.p. rise-times remained fast and unaffected by the toxin. 3. Miniature end-plate potential (m.e.p.p.) frequency was reduced by the toxin to less than 5% of control frequency, and followed a similar time course to the block of e.p.p. amplitudes. The m.e.p.p. rise-time and coefficient of variation (c.v.) of m.e.p.p. amplitude distributions both increased, but the time course of these increases lagged significantly behind the change in frequency. 4. A population of slow rise-time m.e.p.p.s was present in controls at low frequency. This population was found to be unaffected by the toxin. 5. The above-detailed in vitro changes could be explained by the toxin acting by a single common mechanism to inhibit the release process underlying both fast rise-time m.e.p.p.s and e.p.p.s. A distinct release process, which leads to slow rise-time m.e.p.p.s, was unaffected by the toxin.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3681717      PMCID: PMC1192474          DOI: 10.1113/jphysiol.1987.sp016546

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  18 in total

1.  Influence of nerve-ending activity and of drugs on the rate of paralysis of rat diaphragm preparations by Cl. botulinum type A toxin.

Authors:  R HUGHES; B C WHALER
Journal:  J Physiol       Date:  1962-02       Impact factor: 5.182

2.  The antagonism between botulinum toxin and calcium in motor nerve terminals.

Authors:  C B Gundersen; B Katz; R Miledi
Journal:  Proc R Soc Lond B Biol Sci       Date:  1982-10-22

3.  Actions of beta-bungarotoxin on spontaneous release of transmitter at muscle end-plates treated with botulinum toxin.

Authors:  C K Tse; D Wray; J Melling; J O Dolly
Journal:  Toxicon       Date:  1986       Impact factor: 3.033

4.  A new type of transmitter release at the neuromuscular junction.

Authors:  S Thesleff; J Molgó
Journal:  Neuroscience       Date:  1983-05       Impact factor: 3.590

5.  Kinetic studies on the interaction between botulinum toxin type A and the cholinergic neuromuscular junction.

Authors:  L L Simpson
Journal:  J Pharmacol Exp Ther       Date:  1980-01       Impact factor: 4.030

6.  Observations on the action of type A botulinum toxin on frog neuromuscular junctions.

Authors:  D A Boroff; J del Castillo; W H Evoy; R A Steinhardt
Journal:  J Physiol       Date:  1974-07       Impact factor: 5.182

7.  Spontaneous subminature end-plate potentials in mouse diaphragm muscle: evidence for synchronous release.

Authors:  M E Kriebel; F Llados; D R Matteson
Journal:  J Physiol       Date:  1976-11       Impact factor: 5.182

8.  Pre- and post-synaptic actions of botulinum toxin at the rat neuromuscular junction.

Authors:  L C Sellin; S Thesleff
Journal:  J Physiol       Date:  1981-08       Impact factor: 5.182

9.  Preparation and characterisation of homogeneous neurotoxin type A from Clostridium botulinum. Its inhibitory action on neuronal release of acetylcholine in the absence and presence of beta-bungarotoxin.

Authors:  C K Tse; J O Dolly; P Hambleton; D Wray; J Melling
Journal:  Eur J Biochem       Date:  1982-03-01

10.  Prolonged exposure to acetylcholine: noise analysis and channel inactivation in cat tenuissimus muscle.

Authors:  D Wray
Journal:  J Physiol       Date:  1981-01       Impact factor: 5.182

View more
  8 in total

1.  Function Suggests Nano-Structure: Quantitative Structural Support for SNARE-Mediated Pore Formation.

Authors:  Ilan Hammel; Isaac Meilijson
Journal:  Neurotox Res       Date:  2015-09-25       Impact factor: 3.911

Review 2.  Importance of being Nernst: Synaptic activity and functional relevance in stem cell-derived neurons.

Authors:  Aaron B Bradford; Patrick M McNutt
Journal:  World J Stem Cells       Date:  2015-07-26       Impact factor: 5.326

3.  Neurotransmitter release is blocked intracellularly by botulinum neurotoxin, and this requires uptake of both toxin polypeptides by a process mediated by the larger chain.

Authors:  B Poulain; L Tauc; E A Maisey; J D Wadsworth; P M Mohan; J O Dolly
Journal:  Proc Natl Acad Sci U S A       Date:  1988-06       Impact factor: 11.205

4.  Tetrahydroaminoacridine (tacrine) stimulates neurosecretion at mammalian motor endplates.

Authors:  S Thesleff; L C Sellin; S Tågerud
Journal:  Br J Pharmacol       Date:  1990-07       Impact factor: 8.739

5.  Botulinum type F neurotoxin. Large-scale purification and characterization of its binding to rat cerebrocortical synaptosomes.

Authors:  J D Wadsworth; M Desai; H S Tranter; H J King; P Hambleton; J Melling; J O Dolly; C C Shone
Journal:  Biochem J       Date:  1990-05-15       Impact factor: 3.857

6.  Antidotal treatment of botulism in rats by continuous infusion with 3,4-diaminopyridine.

Authors:  James B Machamer; Edwin J Vazquez-Cintron; Sean W O'Brien; Kyle E Kelly; Amber C Altvater; Kathleen T Pagarigan; Parker B Dubee; Celinia A Ondeck; Patrick M McNutt
Journal:  Mol Med       Date:  2022-06-03       Impact factor: 6.376

7.  Botulinum toxin treatment of spasmodic torticollis.

Authors:  T J Anderson; J Rivest; R Stell; M J Steiger; H Cohen; P D Thompson; C D Marsden
Journal:  J R Soc Med       Date:  1992-09       Impact factor: 5.344

8.  Botulinum Neurotoxins Serotypes A and B induce paralysis of mouse striated and smooth muscles with different potencies.

Authors:  Jacquie Maignel-Ludop; Marion Huchet; Johannes Krupp
Journal:  Pharmacol Res Perspect       Date:  2017-01-31
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.